AAAAAA
Results:
1-7
|
Results: 7
Authors:
Sengelov, L
Kamby, C
von der Maase, H
Citation: L. Sengelov et al., Metastatic urothelial cancer: Evaluation of prognostic factors and change in prognosis during the last twenty years, EUR UROL, 39(6), 2001, pp. 634-642
Authors:
Sengelov, L
Frolich, S
Psych, M
Kamby, C
Jensen, NH
Steven, K
Citation: L. Sengelov et al., The functional and psychosocial status of patients with disseminated bladder cancer, UROL ONCOL, 5(1), 2000, pp. 20-24
Authors:
Sengelov, L
Kamby, C
Geertsen, F
Andersen, LJ
von der Maase, H
Citation: L. Sengelov et al., Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer, CANC CHEMOT, 46(5), 2000, pp. 357-364
Authors:
Sengelov, L
Christensen, M
von der Maase, H
Horn, T
Marcussen, N
Kamby, C
Orntoft, T
Citation: L. Sengelov et al., Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelialcancer and lack of relation to chemotherapy response and outcome, CANC GENET, 123(2), 2000, pp. 109-113
Authors:
Kamby, C
Sengelov, L
Citation: C. Kamby et L. Sengelov, Survival and pattern of failure following locoregional recurrence of breast cancer, CL ONCOL-UK, 11(3), 1999, pp. 156-163
Authors:
Sengelov, L
von der Maase, H
Citation: L. Sengelov et H. Von Der Maase, Radiotherapy in bladder cancer, RADIOTH ONC, 52(1), 1999, pp. 1-14
Authors:
Sengelov, L
von der Maase, H
Kamby, C
Jensen, LI
Rasmussen, F
Horn, T
Nielsen, SL
Steven, K
Citation: L. Sengelov et al., Assessment of patients with metastatic transitional cell carcinoma of the urinary tract, J UROL, 162(2), 1999, pp. 343-346
Risultati:
1-7
|